6CM
683 Capital Management Portfolio holdings
AUM
$986M
This Quarter Return
+8.36%
1 Year Return
+26.79%
3 Year Return
+135.86%
5 Year Return
+188.43%
10 Year Return
+750.26%
AUM
$803M
AUM Growth
+$803M
(+4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-18.11%
Top 10 Holdings %
Top 10 Hldgs %
54.41%
Holding
193
New
36
Increased
20
Reduced
21
Closed
30
Top Buys
Top Sells
| 1 |
Traws Pharma
TRAW
|
$99.4M |
| 2 |
Hycroft Mining Holding Corp
HYMC
|
$18.3M |
| 3 |
Larimar Therapeutics
LRMR
|
$16.4M |
| 4 |
XHR
Xenia Hotels & Resorts
XHR
|
$13.4M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
$7.55M |
Sector Composition
| 1 | Healthcare | 28.92% |
| 2 | Communication Services | 21.01% |
| 3 | Consumer Discretionary | 17.75% |
| 4 | Financials | 5.68% |
| 5 | Utilities | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Carvana
CVNA
$51.4B
| $92.3M | 5.99% | 1,561,634 | – | – |
|
|
NIHD
2
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $82.3M | 5.34% | 14,045,499 | – | – |
|
3
TrueCar
TRUE
$195M
| $47.7M | 3.1% | 3,383,358 | – | – |
|
4
Adient
ADNT
$2.01B
| $39.3M | 2.55% | 1,000,000 +130,000 | +15% | +$5.11M |
|
5
uniQure
QURE
$896M
| $35.8M | 2.32% | 984,100 -65,900 | -6% | -$2.4M |
|
|
TRVG
6
trivago
TRVG
$237M
| $34.5M | 2.24% | 5,600,000 +100,000 | +2% | +$616K |
|
|
RDHL
7
Redhill Biopharma
RDHL
$3.1M
| $32.1M | 2.08% | 3,631,019 +1,588,365 | +78% | +$14M |
|
8
Alnylam Pharmaceuticals
ALNY
$58.5B
| $26.3M | 1.7% | 300,000 | – | – |
|
9
PG&E
PCG
$33.6B
| $23.6M | 1.53% | 511,910 -80,000 | -14% | -$3.68M |
|
|
ONDK
10
DELISTED
On Deck Capital, Inc.
ONDK
| $23.1M | 1.5% | 3,050,000 | – | – |
|
11
Aldeyra Therapeutics
ALDX
$351M
| $18.6M | 1.21% | 1,350,000 +350,000 | +35% | +$4.83M |
|
12
Galmed Pharmaceuticals
GLMD
$6.96M
| $18.3M | 1.19% | 1,350,000 | – | – |
|
13
Kroger
KR
$44.9B
| $16.7M | 1.09% | 575,000 -75,000 | -12% | -$2.18M |
|
|
NYRT
14
DELISTED
New York REIT, Inc.
NYRT
| $15.5M | 1.01% | 856,394 +106,395 | +14% | +$1.93M |
|
|
IRS
15
IRSA Inversiones y Representaciones
IRS
$1.11B
| $14.3M | 0.93% | 841,071 +174,771 | +26% | +$2.96M |
|
16
Enova International
ENVA
$3.03B
| $13.4M | 0.87% | 465,000 -66,449 | -13% | -$1.91M |
|
17
NOV
NOV
$4.94B
| $12.7M | 0.82% | 295,000 | – | – |
|
18
Micron Technology
MU
$133B
| $12.7M | 0.82% | 280,000 -50,000 | -15% | -$2.26M |
|
|
CRESY
19
Cresud
CRESY
$615M
| $11.7M | 0.76% | 824,314 +142,814 | +21% | +$2.02M |
|
|
MRNS
20
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $11M | 0.71% | 1,100,000 -100,000 | -8% | -$1M |
|
21
Fate Therapeutics
FATE
$120M
| $10.6M | 0.69% | 649,800 -94,211 | -13% | -$1.53M |
|
22
Energy Recovery
ERII
$756M
| $9.85M | 0.64% | 1,100,000 | – | – |
|
23
Edison International
EIX
$21.6B
| $8.12M | 0.53% | 120,000 +20,000 | +20% | +$1.35M |
|
|
AVEO
24
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $8.11M | 0.53% | 2,449,800 -50,200 | -2% | -$166K |
|
25
Fennec Pharmaceuticals
FENC
$247M
| $7.97M | 0.52% | 971,351 +104,166 | +12% | +$854K |
|